Turner S J, Domin J, Waterfield M D, Ward S G, Westwick J
Pharmacology Group, Department of Pharmacy and Pharmacology, Bath University, Claverton Down, Bath, Avon BA2 7AY, United Kingdom.
J Biol Chem. 1998 Oct 2;273(40):25987-95. doi: 10.1074/jbc.273.40.25987.
The cellular effects of MCP-1 are mediated primarily by binding to CC chemokine receptor-2. We report here that MCP-1 stimulates the formation of the lipid products of phosphatidylinositol (PI) 3-kinase, namely phosphatidylinositol 3,4-bisphosphate and phosphatidylinositol 3,4,5-trisphosphate (PI 3,4,5-P3) in THP-1 cells that can be inhibited by pertussis toxin but not wortmannin. MCP-1 also stimulates an increase in the in vitro lipid kinase activity present in immunoprecipitates of the class 1A p85/p110 heterodimeric PI 3-kinase, although the kinetics of activation were much slower than observed for the accumulation of PI 3,4,5-P3. In addition, this in vitro lipid kinase activity was inhibited by wortmannin (IC50 = 4.47 +/- 1.88 nM, n = 4), and comparable concentrations of wortmannin also inhibited MCP-stimulated chemotaxis of THP-1 cells (IC50 = 11.8 +/- 4.2 nM, n = 4), indicating that p85/p110 PI 3-kinase activity is functionally relevant. MCP-1 also induced tyrosine phosphorylation of three proteins in these cells, and a fourth tyrosine-phosphorylated protein co-precipitates with the p85 subunit upon MCP-1 stimulation. In addition, MCP-1 stimulated lipid kinase activity present in immunoprecipitates of a class II PI 3-kinase (PI3K-C2alpha) with kinetics that closely resembled the accumulation of PI 3,4,5-P3. Moreover, this MCP-1-induced increase in PI3K-C2alpha activity was insensitive to wortmannin but was inhibited by pertussis toxin pretreatment. Since this mirrored the effects of these inhibitors on MCP-1-stimulated increases in D-3 phosphatidylinositol lipid accumulation in vivo, these results suggest that activation of PI3K-C2alpha rather than the p85/p110 heterodimer is responsible for mediating the in vivo formation of D-3 phosphatidylinositol lipids. These data demonstrate that MCP-1 stimulates protein tyrosine kinases as well as at least two separate PI 3-kinase isoforms, namely the p85/p110 PI 3-kinase and PI3K-C2alpha. This is the first demonstration that MCP-1 can stimulate PI 3-kinase activation and is also the first indication of an agonist-induced activation of the PI3K-C2alpha enzyme. These two events may play important roles in MCP-1-stimulated signal transduction and biological consequences.
单核细胞趋化蛋白-1(MCP-1)的细胞效应主要通过与CC趋化因子受体-2结合来介导。我们在此报告,MCP-1可刺激THP-1细胞中磷脂酰肌醇(PI)3激酶的脂质产物形成,即磷脂酰肌醇3,4-二磷酸和磷脂酰肌醇3,4,5-三磷酸(PI 3,4,5-P3),百日咳毒素可抑制这种刺激作用,而渥曼青霉素则不能。MCP-1还可刺激1A类p85/p110异二聚体PI 3激酶免疫沉淀物中体外脂质激酶活性的增加,尽管其激活动力学比PI 3,4,5-P3的积累要慢得多。此外,这种体外脂质激酶活性受到渥曼青霉素的抑制(IC50 = 4.47 +/- 1.88 nM,n = 4),且相当浓度的渥曼青霉素也抑制MCP刺激的THP-1细胞趋化作用(IC50 = 11.8 +/- 4.2 nM,n = 4),这表明p85/p110 PI 3激酶活性具有功能相关性。MCP-1还可诱导这些细胞中三种蛋白质的酪氨酸磷酸化,并且在MCP-1刺激后,第四种酪氨酸磷酸化蛋白质与p85亚基共沉淀。此外,MCP-1可刺激II类PI 3激酶(PI3K-C2α)免疫沉淀物中的脂质激酶活性,其动力学与PI 3,4,5-P3的积累非常相似。而且,MCP-1诱导的PI3K-C2α活性增加对渥曼青霉素不敏感,但受到百日咳毒素预处理的抑制。由于这反映了这些抑制剂对MCP-1刺激的体内D-3磷脂酰肌醇脂质积累增加的影响,这些结果表明PI3K-C2α而非p85/p110异二聚体的激活负责介导体内D-3磷脂酰肌醇脂质的形成。这些数据表明,MCP-1可刺激蛋白酪氨酸激酶以及至少两种不同的PI 3激酶同工型,即p85/p110 PI 3激酶和PI3K-C2α。这是首次证明MCP-1可刺激PI 3激酶激活,也是首次表明激动剂诱导PI3K-C2α酶激活。这两个事件可能在MCP-1刺激的信号转导和生物学后果中发挥重要作用。